An investigational drug called ZS-9 demonstrated promising Phase 2 clinical trial results for treating abnormally high potassium levels in patients with chronic kidney disease.The immune drug abatacept did not provide benefits above standard treatment for patients with kidney inflammation caused by lupus.
Fuente : http://www.eurekalert.org/pub_releases/2013-11/aso...
Fuente : http://www.eurekalert.org/pub_releases/2013-11/aso...